Form 4 for DERM Journey Medical Corp
Accepted 2025-06-20 00:00:00 ET · period of report 2025-06-17 · accession 0001104659-25-061149 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-20 | 2025-06-17 | DERM | Maraoui Claude | Pres, CEO, Dir | A - Grant | $0.00 | +49.3K | 2.40M | +2% | $0 |
| D | 2025-06-20 | 2025-06-17 | DERM | Maraoui Claude | Pres, CEO, Dir | A - Grant | $0.00 | +82.9K | 82.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.0001 par value | 2025-06-17 | A | A | 49,277 | $0.00 | 2,397,590 | D | — | — | (F1) On June 17, 2025, the reporting person was granted 49,277 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 16,426 shares on January 1, 2026, 16,426 shares on January 1, 2027 and 16,425 shares on January 1, 2028. (F2) Includes restricted stock units, which vest over various time periods. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-06-17 | A | A | 82,915 | $0.00 | 82,915 | D | $6.31 · — to 2035-06-17 | 82,915 Common Stock, $0.0001 par value | (F3) On June 17, 2025, the reporting person was granted 82,915 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that will vest in accordance with the following schedule: 27,638 shares on January 1, 2026, 27,638 shares on January 1, 2027 and 27,639 shares on January 1, 2028. |